Overview

Safety and Efficacy Study to Compare Two Rosacea Treatment Regimens

Status:
Completed
Trial end date:
2007-12-01
Target enrollment:
0
Participant gender:
All
Summary
To compare the safety and efficacy of two treatment regimens: 1) COL-101 and metronidazole gel 1%; 2) Doxycycline hyclate 100 mg and metronidazole gel 1%
Phase:
Phase 4
Accepts Healthy Volunteers?
Accepts Healthy Volunteers
Details
Lead Sponsor:
CollaGenex Pharmaceuticals
Treatments:
Doxycycline
Metronidazole
Criteria
Inclusion Criteria:

- 8-40 total lesions

- erythema

- telangiectasia

Exclusion Criteria:

- non-pregnant, non-lactating

- achlorhydric

- gastric by-pass surgery

- allergy to study medications

- drug/alcohol abuse

- use of proton pump inhibitors